MBX Competitors & Alternatives
Compare MBX Biosciences, Inc. Common Stock with similar stocks in the same industry
Biotechnology
MBX
Main Stock$57.72
Tradestie Score
36
Market Cap
$800.41M
Analyst Upside
+65.8%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc
|
$42.10
|
$3.02B | - | 29 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$72.61
|
$3.01B | - | 33 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$16.70
|
$2.89B | - | 29 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$37.04
|
$2.85B | - | 43 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.49
|
$2.56B | 18.2 | 51 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$25.81
|
$2.44B | - | 46 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$76.76
|
$2.42B | - | 54 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$155.94
|
$2.41B | - | 51 | Compare |
More MBX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry